Causes of death identified in neonates enrolled through Child Health and Mortality Prevention Surveillance (CHAMPS), December 2016 -December 2021.


Journal

PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676

Informations de publication

Date de publication:
2023
Historique:
received: 22 08 2022
accepted: 27 01 2023
entrez: 24 3 2023
pubmed: 25 3 2023
medline: 25 3 2023
Statut: epublish

Résumé

Each year, 2.4 million children die within their first month of life. Child Health and Mortality Prevention Surveillance (CHAMPS) established in 7 countries aims to generate accurate data on why such deaths occur and inform prevention strategies. Neonatal deaths that occurred between December 2016 and December 2021 were investigated with MITS within 24-72 hours of death. Testing included blood, cerebrospinal fluid and lung cultures, multi-pathogen PCR on blood, CSF, nasopharyngeal swabs and lung tissue, and histopathology examination of lung, liver and brain. Data collection included clinical record review and family interview using standardized verbal autopsy. The full set of data was reviewed by local experts using a standardized process (Determination of Cause of Death) to identify all relevant conditions leading to death (causal chain), per WHO recommendations. For analysis we stratified neonatal death into 24-hours of birth, early (1-<7 days) and late (7-<28 days) neonatal deaths. We analyzed 1458 deaths, 41% occurring within 24-hours, 41% early and 18% late neonatal deaths. Leading underlying causes of death were complications of intrapartum events (31%), complications of prematurity (28%), infections (17%), respiratory disorders (11%), and congenital malformations (8%). In addition to the underlying cause, 62% of deaths had additional conditions and 14% had ≥3 other conditions in the causal chain. The most common causes considering the whole causal chain were infection (40%), prematurity (32%) and respiratory distress syndrome (28%). Common maternal conditions linked to neonatal death were maternal hypertension (10%), labour and delivery complications (8%), multiple gestation (7%), placental complications (6%) obstructed labour and chorioamnionitis (5%, each). CHAMPS' findings showing the full causal chain of events that lead to death, in addition to maternal factors, highlights the complexities involved in each death along with the multiple opportunities for prevention. Highlighting improvements to prenatal and obstetric care and infection prevention are urgently needed in high-mortality settings.

Identifiants

pubmed: 36963040
doi: 10.1371/journal.pgph.0001612
pii: PGPH-D-22-01311
pmc: PMC10027211
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e0001612

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

Copyright: © 2023 Mahtab et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Front Public Health. 2020 Oct 30;8:595379
pubmed: 33194998
Clin Infect Dis. 2019 Oct 9;69(Suppl 4):S262-S273
pubmed: 31598664
Lancet Glob Health. 2018 Dec;6(12):e1297-e1308
pubmed: 30361107
Clin Infect Dis. 2019 Oct 9;69(Suppl 4):S302-S310
pubmed: 31598667
PLoS Med. 2016 Nov 22;13(11):e1002172
pubmed: 27875532
Health Technol Assess. 2019 Aug;23(46):1-104
pubmed: 31461397
BJOG. 2022 Nov;129(12):1993-2000
pubmed: 35593030
Ann Glob Health. 2019 Jul 03;85(1):
pubmed: 31276331
Clin Infect Dis. 2019 Oct 9;69(Suppl 4):S274-S279
pubmed: 31598663
Lancet. 2018 Jul 14;392(10142):145-159
pubmed: 30025808
S Afr Med J. 2002 Nov;92(11):897-901
pubmed: 12506592
Clin Infect Dis. 2019 Oct 9;69(Suppl 4):S311-S321
pubmed: 31598666
Pediatr Res. 2013 Dec;74 Suppl 1:50-72
pubmed: 24366463
Clin Infect Dis. 2019 Oct 9;69(Suppl 4):S351-S360
pubmed: 31598660
Lancet Glob Health. 2019 Jun;7(6):e710-e720
pubmed: 31097275
Best Pract Res Clin Obstet Gynaecol. 2007 Aug;21(4):609-24
pubmed: 17400026
PLoS One. 2021 Mar 16;16(3):e0248143
pubmed: 33725013
Lancet. 2017 Dec 17;388(10063):3027-3035
pubmed: 27839855
Am J Trop Med Hyg. 2020 Oct;103(4):1670-1680
pubmed: 32748779
Yonsei Med J. 2016 Mar;57(2):426-9
pubmed: 26847296
S Afr Med J. 2020 Apr 29;110(5):360-363
pubmed: 32657717
Clin Infect Dis. 2019 Oct 9;69(Suppl 4):S322-S332
pubmed: 31598668
JAMA Netw Open. 2022 Oct 3;5(10):e2237689
pubmed: 36269354
Clin Infect Dis. 2019 Oct 9;69(Suppl 4):S333-S341
pubmed: 31598661
Lancet Glob Health. 2020 Jul;8(7):e909-e919
pubmed: 32562647

Auteurs

Sana Mahtab (S)

South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.

Shabir A Madhi (SA)

South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.

Vicky L Baillie (VL)

South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.

Toyah Els (T)

South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.

Bukiwe Nana Thwala (BN)

South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.

Dickens Onyango (D)

Kenya County Department of Health, Kisumu, Kenya.

Beth A Tippet-Barr (BA)

Centers for Disease Control and Prevention, Kisumu, Kenya.

Victor Akelo (V)

Centers for Disease Control and Prevention, Kisumu, Kenya.

Kitiezo Aggrey Igunza (KA)

Kenya Medical Research Institute-Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.

Richard Omore (R)

Kenya Medical Research Institute-Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.

Shams El Arifeen (SE)

International Center for Diarrhoeal Diseases Research (icddr,b), Dhaka, Bangladesh.

Emily S Gurley (ES)

International Center for Diarrhoeal Diseases Research (icddr,b), Dhaka, Bangladesh.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.

Muntasir Alam (M)

International Center for Diarrhoeal Diseases Research (icddr,b), Dhaka, Bangladesh.

Atique Iqbal Chowdhury (AI)

International Center for Diarrhoeal Diseases Research (icddr,b), Dhaka, Bangladesh.

Afruna Rahman (A)

International Center for Diarrhoeal Diseases Research (icddr,b), Dhaka, Bangladesh.

Quique Bassat (Q)

ISGlobal-Hospital Clínic, Unversitat de Barcelona, Barcelona, Spain.
Centro de Investigação em Saúde de Manhiça [CISM], Maputo, Mozambique.
Institutó Catalana de Recerca I Estudis Avançats [ICREA], Barcelona, Spain.
Hospital Sant Joan de Déu, Universitat de Barcelona, Esplugues, Barcelona, Spain.
Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública [CIBERESP], Madrid, Spain.

Inacio Mandomando (I)

Centro de Investigação em Saúde de Manhiça [CISM], Maputo, Mozambique.
Instituto Nacional de Saúde [INS], Maputo, Mozambique.

Sara Ajanovic (S)

ISGlobal-Hospital Clínic, Unversitat de Barcelona, Barcelona, Spain.

Antonio Sitoe (A)

Centro de Investigação em Saúde de Manhiça [CISM], Maputo, Mozambique.

Rosauro Varo (R)

ISGlobal-Hospital Clínic, Unversitat de Barcelona, Barcelona, Spain.
Centro de Investigação em Saúde de Manhiça [CISM], Maputo, Mozambique.

Samba O Sow (SO)

Centre pour le Développement des Vaccins (CVD-Mali), Ministère de la Santé, Bamako, Mali.

Karen L Kotloff (KL)

Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.

Henry Badji (H)

Centre pour le Développement des Vaccins (CVD-Mali), Ministère de la Santé, Bamako, Mali.

Milagritos D Tapia (MD)

Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.

Cheick B Traore (CB)

Department of Pathological Anatomy and Cytology, University Hospital of Point G, Bamako, Mali.

Ikechukwu U Ogbuanu (IU)

Crown Agents, Freetown, Sierra Leone.

James Bunn (J)

World Health Organization-Sierra Leone, Freetown, Sierra Leone.

Ronita Luke (R)

Ola During Children's Hospital, Freetown, Sierra Leone.

Sulaiman Sannoh (S)

St. Luke's University Health Network, Easton, Pennsylvania, United States of America.

Alim Swarray-Deen (A)

University of Ghana Medical School, Accra, Ghana.

Nega Assefa (N)

College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.

J Anthony G Scott (JAG)

Department of Infectious Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Lola Madrid (L)

College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
Department of Infectious Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Dadi Marami (D)

College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.

Surafel Fentaw (S)

Bacterial and Mycology Unit, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Maureen H Diaz (MH)

Respiratory Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Roosecelis B Martines (RB)

Infectious Diseases Pathology Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Robert F Breiman (RF)

Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.

Zachary J Madewell (ZJ)

Center for Global Health, US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Dianna M Blau (DM)

Center for Global Health, US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Cynthia G Whitney (CG)

Emory Global Health Institute, Emory University, Atlanta, Georgia, United States of America.

Classifications MeSH